Wikipedia -WSS

Wikipedia

author：fashion 2025-09-29 03:40:02 - browse：642

Stock exchange — Drew Angerer/Getty Images

Structure Therapeutics reported Monday that its oral GLP-1 drug led to weight loss in two small studies, leading shares to surge in pre-market trading.

In a 12-week Phase 2a study, the daily pill in a capsule formulation led to 6.2% placebo-adjusted weight loss. In a separate 12-week pharmacokinetics study, the company tested a new tablet formulation of the drug, called GSBR-1290, and it led to placebo-adjusted weight loss of up to 6.9%.

Though it’s difficult to compare across different studies, the results appear to approach the levels of weight loss seen at 12 weeks in a separate Phase 2 study of Eli Lilly’s GLP-1 pill called orforglipron. That entire study lasted 36 weeks, but at 12 weeks, participants had about 6%-7% placebo-adjusted weight loss.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Twill hunts for pharma partner to market its depression app

WSS

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Readout Newsletter: BridgeBio, Akero, and human embryo models

Readout Newsletter: BridgeBio, Akero, and human embryo models

Why you get paid to donate plasma but not blood

Pregnant women don't need prenatal multivitamins, study concludes

Why Talkspace is targeting Medicare, a tricky market

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why Talkspace is targeting Medicare, a tricky market

Sports medicine is finally prioritizing gender equality

Lack of darker skin in textbooks, journals harms patients of color

Alkermes shareholders re

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Malaria cases in Florida and Texas: Here’s what you need to know

Medicare drug price negotiation continues, as pharma counteroffers

In age of alternative facts, a scholarly course on calling out crap

Harvard's David Sinclair gets blowback over aging

hotspot

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Immune cells and nerve overgrowth may explain recurring UTI pain

Stem cell biologist probes earliest stages of human development

He's 19 months old and has one of the world’s rarest diseases

More hospitals are billing patients as online messages surge

House passes resolution saying Israel isn't a 'racist or apartheid state'

hotspot

focus

explore

hotspot